Evidence map›Paper›PMID 19942596›Full record

ArticleMutagenesis2010

Newly identified CHO ERCC3/XPB mutations and phenotype characterization.

Ivana Rybanská, Ján Gursky, Miriam Fasková, Edmund P Salazar, Erika Kimlícková-Polakovicová, Karol Kleibl, Larry H Thompson, Miroslav Pirsel

Open access · bronzeAbstract read
In one paragraph

Article in Mutagenesis, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Ivana RybanskáLaboratory of Molecular Genetics, Cancer Research Institute, Slovak Academy of Sciences, Vlárska 7, 833 91 Bratislava 37, Slovak Republic.
Ján Gursky
Miriam Fasková
Edmund P Salazar
Erika Kimlícková-Polakovicová
Karol Kleibl
Larry H Thompson
Miroslav Pirsel
Slovak Academy of Sciences · SKLawrence Livermore National Laboratory · USLaboratory of Molecular Genetics · PL

Funding

FANCONI ANEMIA GENE PATHWAY IN RADIATION RESPONSESR01CA089405 · NCI · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI THOMPSON, LAWRENCE H · 2001 to 2004
$1.5M
Homologous Recombination & Human Cell RadiosensitivityR01CA112566 · NCI · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI THOMPSON, LAWRENCE H · 2006 to 2009
$1.4M
NCI NIH HHS CA112566NCI NIH HHS CA89405NCI NIH HHS R01 CA089405NCI NIH HHS R01 CA112566
6 · The paper itself

Abstract

Nucleotide excision repair (NER) is a complex multistage process involving many interacting gene products to repair a wide range of DNA lesions. Genetic defects in NER cause human hereditary diseases including xeroderma pigmentosum (XP), Cockayne syndrome (CS), trichothiodystrophy and a combined XP/CS overlapping symptom. One key gene product associated with all these disorders is the excision repair cross-complementing 3/xeroderma pigmentosum B (ERCC3/XPB) DNA helicase, a subunit of the transcription factor IIH complex. ERCC3 is involved in initiation of basal transcription and global genome repair as well as in transcription-coupled repair (TCR). The hamster ERCC3 gene shows high degree of homology with the human ERCC3/XPB gene. We identified new mutations in the Chinese hamster ovary cell ERCC3 gene and characterized the role of hamster ERCC3 protein in DNA repair of ultraviolet (UV)-induced and oxidative DNA damage. All but one newly described mutations are located in the protein C-terminal region around the last intron-exon boundary. Due to protein truncations or frameshifts, they lack amino acid Ser751, phosphorylation of which prevents the 5' incision of the UV-induced lesion during NER. Thus, despite the various locations of the mutations, their phenotypes are similar. All ercc3 mutants are extremely sensitive to UV-C light and lack recovery of RNA synthesis (RRS), confirming a defect in TCR of UV-induced damage. Their limited global genome NER capacity averages approximately 8%. We detected modest sensitivity of ercc3 mutants to the photosensitizer Ro19-8022, which primarily introduces 8-oxoguanine lesions into DNA. Ro19-8022-induced damage interfered with RRS, and some of the ercc3 mutants had delayed kinetics. All ercc3 mutants showed efficient base excision repair (BER). Thus, the positions of the mutations have no effect on the sensitivity to, and repair of, Ro19-8022-induced DNA damage, suggesting that the ERCC3 protein is not involved in BER.

Indexed as

AnimalsCell SurvivalCHO CellsComet AssayCricetinaeCricetulusDNA-Binding ProteinsDNA DamageDNA-Formamidopyrimidine GlycosylaseDNA HelicasesMutationPhenotypePyrrolidinesQuinolizinesUltraviolet RaysDNA-Binding ProteinsDNA-Formamidopyrimidine GlycosylaseDNA HelicasesPyrrolidinesQuinolizinesRo 19-8022XPBC-ERCC-3 protein

Identifiers

PMID19942596
PMCPMC2825344
OpenAlexW2098439928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.